Smart-phone Application Versus Conventional Paper for the Documentation of Voiding Dysfunction in Children
Launched by KING ABDULLAH INTERNATIONAL MEDICAL RESEARCH CENTER · May 5, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two ways for children with voiding dysfunction, which means problems with urination, to keep track of their bathroom habits. The researchers want to find out if using a smart-phone app called DryDawn® is better than using a traditional paper diary. They will compare how much information each method provides and how satisfied the participants are with each option.
To be eligible for the study, children must be between six and eighteen years old and need to have a voiding issue that requires them to keep a diary. It's important that they also have a smart-phone since the app can only be used on those devices. Participants will fill out a questionnaire to share their thoughts about the methods used in the study. This trial is not yet recruiting participants, but it aims to help improve ways to track and understand voiding dysfunction in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • New patients who have a voiding dysfunction that necessitates the use of a voiding diary
- • Children ages six (6) to eighteen (18) years
- • Participants must own a smart-phone
- Exclusion Criteria:
- • Children less than six (6) years of age
- • Participants who do not own a smart-phone
About King Abdullah International Medical Research Center
The King Abdullah International Medical Research Center (KAIMRC) is a leading institution dedicated to advancing healthcare through innovative research and clinical trials. Established to support and enhance medical research in alignment with the Kingdom of Saudi Arabia's Vision 2030, KAIMRC focuses on a wide range of health issues, aiming to improve patient outcomes and foster scientific collaboration. With a commitment to ethical standards and rigorous methodologies, KAIMRC facilitates the translation of research findings into clinical practice, making significant contributions to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Amr Hodhod, MD, PhD, Msc
Principal Investigator
King Abdullah International Medical Research Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported